NCT00445874View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

May 31, 2007

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Ketotifen with a Contact Lens (no generic name)

Trial Locations (7)

85032

Phoenix

Unknown

Phoenix

Irvine

North Andover

Cincinnati

Fairfield

Mason

All Listed Sponsors
lead

Vistakon Pharmaceuticals

INDUSTRY

NCT00445874 - Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis | Biotech Hunter | Biotech Hunter